A temporal examination of inspiratory muscle strength and
endurance in hospitalized COVID-19 patients

J 2023

A temporal examination of inspiratory muscle strength and endurance in hospitalized COVID-19 patients

DOSBABA, Filip, Martin HARTMAN, Ladislav BAŤALÍK, Vojtěch ŠENKÝŘ, Ivana RADKOVCOVÁ et. al.

Základní údaje

Originální název

A temporal examination of inspiratory muscle strength and endurance in hospitalized COVID-19 patients

Autoři

DOSBABA, Filip (203 Česká republika, garant), Martin HARTMAN (203 Česká republika), Ladislav BAŤALÍK (203 Česká republika, domácí), Vojtěch ŠENKÝŘ, Ivana RADKOVCOVÁ (203 Česká republika), Svatopluk RICHTER (203 Česká republika), Kristián BRAT (703 Slovensko), L. P. CAHALIN a M. F. FORMIGA

Vydání

HEART & LUNG, NEW YORK, MOSBY-ELSEVIER, 2023, 0147-9563

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30307 Nursing

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.800 v roce 2022

Kód RIV

RIV/00216224:14110/23:00130466

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1016/j.hrtlng.2023.03.007

UT WoS

000959317300001

Klíčová slova anglicky

COVID-19; Inspiratory muscle performance; Inspiratory muscle endurance; Maximal inspiratory pressures; Test of Incremental Respiratory Endurance

Štítky

14110525, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 11. 5. 2023 09:02, Mgr. Tereza Miškechová

Anotace

V originále

Background: The two most common symptoms associated with COVID-19 are dyspnea and fatigue. One possible cause of such symptoms may be inspiratory muscle weakness.Objectives: The purpose of this study was to examine inspiratory muscle performance (IMP) from intensive care unit discharge (ICUD) to hospital discharge (HD) in patients with COVID-19 hypothesizing that IMP would be markedly depressed at both ICUD and HD. Methods: IMP was examined at ICUD and HD via the PrO2 device (PrO2 Health, Smithfield, RI) which provided the maximal inspiratory pressure (MIP), sustained MIP (SMIP), inspiratory duration (ID), and fatigue index test (FIT). Patient symptoms were assessed at ICUD, HD, and 1-month post-HD. Results: 30 patients (19 men, 11 women) with COVID-19 were included. The mean +/- SD age, BMI, and length of ICU and hospital stay was 71 +/- 11 yrs, 27.9 +/- 6.3 kg/m, 9 +/- 6 days, and 26 +/- 16 days, respectively. The mean +/- SD MIP, SMIP, ID, and FIT of the entire cohort at ICUD vs HD were 36 +/- 21 vs 40 +/- 20 cm H2O, 231 +/- 157 vs 297 +/- 182 PTU, 8.8 +/- 4.2 vs 9.5 +/- 4.6 s, and 9.0 +/- 9.4 vs 13.1 +/- 12.3, respectively, with only SMIP and FIT significantly greater at HD (p=.006 and 0.03, respectively). SMIP at HD was significantly related to resting dyspnea at HD (r=-0.40; p=.02). The SMIP and FIT of men were found to increase significantly from ICUD to HD, but no measure of IMP in the women increased significantly from ICUD to HD. At least one COVID-19related symptom was present 1 month after HD with the most persistent symptoms being fatigue, cough, and dyspnea in 47%, 40%, and 37% of the patients, respectively.Conclusions: A significant reduction in IMP exists in patients with COVID-19 at both ICUD and HD and no measure of IMP in women was observed to increase significantly from ICUD to HD. Impaired inspiratory muscle endurance rather than strength was associated with greater dyspnea at HD. (c) 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Citovat

DOSBABA, Filip, Martin HARTMAN, Ladislav BAŤALÍK, Vojtěch ŠENKÝŘ, Ivana RADKOVCOVÁ, Svatopluk RICHTER, Kristián BRAT, L. P. CAHALIN a M. F. FORMIGA. A temporal examination of inspiratory muscle strength and endurance in hospitalized COVID-19 patients. HEART & LUNG. NEW YORK: MOSBY-ELSEVIER, 2023, roč. 60, July-August 2023, s. 95-101. ISSN 0147-9563. Dostupné z: https://dx.doi.org/10.1016/j.hrtlng.2023.03.007.

@article{2267981,
   author = {Dosbaba, Filip and Hartman, Martin and Baťalík, Ladislav and Šenkýř, Vojtěch and Radkovcová, Ivana and Richter, Svatopluk and Brat, Kristián and Cahalin, L. P. and Formiga, M. F.},
   article_location = {NEW YORK},
   article_number = {July-August 2023},
   doi = {http://dx.doi.org/10.1016/j.hrtlng.2023.03.007},
   keywords = {COVID-19; Inspiratory muscle performance; Inspiratory muscle endurance; Maximal inspiratory pressures; Test of Incremental Respiratory Endurance},
   language = {eng},
   issn = {0147-9563},
   journal = {HEART & LUNG},
   title = {A temporal examination of inspiratory muscle strength and endurance in hospitalized COVID-19 patients},
   url = {https://www.sciencedirect.com/science/article/pii/S0147956323000705?via%3Dihub},
   volume = {60},
   year = {2023}
}

TY  - JOUR
ID  - 2267981
AU  - Dosbaba, Filip - Hartman, Martin - Baťalík, Ladislav - Šenkýř, Vojtěch - Radkovcová, Ivana - Richter, Svatopluk - Brat, Kristián - Cahalin, L. P. - Formiga, M. F.
PY  - 2023
TI  - A temporal examination of inspiratory muscle strength and endurance in hospitalized COVID-19 patients
JF  - HEART & LUNG
VL  - 60
IS  - July-August 2023
SP  - 95-101
EP  - 95-101
PB  - MOSBY-ELSEVIER
SN  - 01479563
KW  - COVID-19
KW  - Inspiratory muscle performance
KW  - Inspiratory muscle endurance
KW  - Maximal inspiratory pressures
KW  - Test of Incremental Respiratory Endurance
UR  - https://www.sciencedirect.com/science/article/pii/S0147956323000705?via%3Dihub
N2  - Background: The two most common symptoms associated with COVID-19 are dyspnea and fatigue. One possible cause of such symptoms may be inspiratory muscle weakness.Objectives: The purpose of this study was to examine inspiratory muscle performance (IMP) from intensive care unit discharge (ICUD) to hospital discharge (HD) in patients with COVID-19 hypothesizing that IMP would be markedly depressed at both ICUD and HD. Methods: IMP was examined at ICUD and HD via the PrO2 device (PrO2 Health, Smithfield, RI) which provided the maximal inspiratory pressure (MIP), sustained MIP (SMIP), inspiratory duration (ID), and fatigue index test (FIT). Patient symptoms were assessed at ICUD, HD, and 1-month post-HD. Results: 30 patients (19 men, 11 women) with COVID-19 were included. The mean +/- SD age, BMI, and length of ICU and hospital stay was 71 +/- 11 yrs, 27.9 +/- 6.3 kg/m, 9 +/- 6 days, and 26 +/- 16 days, respectively. The mean +/- SD MIP, SMIP, ID, and FIT of the entire cohort at ICUD vs HD were 36 +/- 21 vs 40 +/- 20 cm H2O, 231 +/- 157 vs 297 +/- 182 PTU, 8.8 +/- 4.2 vs 9.5 +/- 4.6 s, and 9.0 +/- 9.4 vs 13.1 +/- 12.3, respectively, with only SMIP and FIT significantly greater at HD (p=.006 and 0.03, respectively). SMIP at HD was significantly related to resting dyspnea at HD (r=-0.40; p=.02). The SMIP and FIT of men were found to increase significantly from ICUD to HD, but no measure of IMP in the women increased significantly from ICUD to HD. At least one COVID-19related symptom was present 1 month after HD with the most persistent symptoms being fatigue, cough, and dyspnea in 47%, 40%, and 37% of the patients, respectively.Conclusions: A significant reduction in IMP exists in patients with COVID-19 at both ICUD and HD and no measure of IMP in women was observed to increase significantly from ICUD to HD. Impaired inspiratory muscle endurance rather than strength was associated with greater dyspnea at HD. (c) 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
ER  -

DOSBABA, Filip, Martin HARTMAN, Ladislav BAŤALÍK, Vojtěch ŠENKÝŘ, Ivana RADKOVCOVÁ, Svatopluk RICHTER, Kristián BRAT, L. P. CAHALIN a M. F. FORMIGA. A temporal examination of inspiratory muscle strength and endurance in hospitalized COVID-19 patients. \textit{HEART \&{} LUNG}. NEW YORK: MOSBY-ELSEVIER, 2023, roč.~60, July-August 2023, s.~95-101. ISSN~0147-9563. Dostupné z: https://dx.doi.org/10.1016/j.hrtlng.2023.03.007.

Podrobný výpis o publikaci